Spray-dried redispersible emulsion to improve oral bioavailability of itraconazole

Journal of Surfactants and Detergents

Volumn 17, Issue 4, 2014, Pages 807-817

  Rao, Monica R P ^a   Aghav, Shital S ^a  

^a AISSMS COLLEGE OF PHARMACY   (India)

Author keywords

Dry emulsion; Freeze thaw cycle; Itraconazole; Spray drying; TBCP; TPGS

Indexed keywords

EID: 84903604020     PISSN: 10973958     EISSN: 15589293     Source Type: Journal    
DOI: 10.1007/s11743-013-1538-1     Document Type: Article

References (46)

1. Carrigan PJ, Bates TR (1975) Biopharmaceutics of drugs administered in lipid-containing dosage forms. I. GI absorption of griseofulvin from an oil in water emulsion in the rat. J Pharm Sci 62:1476-1479
2. Humberstone AJ, Charman WN (1997) Lipid based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 25:103-128
3. Charman WN (2000) Lipids, lipophilic drugs, and oral drug delivery: some emerging concepts. J Pharm Sci 89:967-978
4. Charman WN, Porter CJH, Mithani S, Dressman JBA (1997) Physicochemical and physiological mechanisms for the effects of food on drug absorption: the effect of lipids and pH. J Pharm Sci 86:269-282
5. Richter VA, Steiger-Trippi K (1961) Untersuchungen über die zer- stäubungstrocknung von emulgierten arzneizubereitungen. Pharma Acta Helv 36:322-337
6. Lladser M, Medrano C, Aranciba A (1968) The use of supports in the lyophilization of oil-in-water emulsions. J Pharm Pharmacol 20:450-455
7. Myers SL, Shively ML (1993) Solid state emulsion: the effect of maltodextrin on microcrystalline aging. Pharm Res 10:1389-1391
8. Shively ML, Thompson DC (1995) Oral bioavailability of vancomycin solid-state emulsions. Int J Pharm 117:119-122
9. Takeuchi H, Sasaki H, Niwa T, Hino T, Kawashima Y, Uesugi K, Osawa H (1991) Redispersible dry emulsion system as novel oral dosage form of oily drugs: in vivo studies in beagle dogs. Chem Pharm Bull 39:3362-3364
10. Porter CJH, Charman SA, Williams RD et al (1996) Evaluation of emulsifiable glasses for the oral administration of cyclosporine in beagle dogs. Int J Pharm 141:227-237
11. Saag MS, Dismukes WE (1988) Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother 32:1-8
12. Odds FC, Oris M, Dorsselaer PV, Gerven FV (2000) Activities of an intravenous formulation of itraconazole in experimental disseminated Aspergillus, Candida, and Cryptococcus infections. Antimicrob Agents Chemother 44:3180-3183
13. Grant SM, Clissold SP (1989) Itraconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 37:310-344
14. Beule D, Van K, Gestel J (2001) Pharmacology of itraconazole. Drugs 61(Suppl. 1):27-33
15. Verreck G, Six K, den Mooter GV et al (2003) Characterization of solid dispersions of itraconazole and hydroxyl propyl methyl cellulose prepared by melt extrusion: part I. Int J Pharm 251:165-174
16. Hong JY, Kim JK, Song YK et al (2006) A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J Control Release 110:332-338
17. Peeters J, Neeskens P, Tollenaere JP et al (2002) Characterization of the interaction of 2-hydroxypropyl-b-cyclodextrin with itraconazole at pH 2, 4 and 7. J Pharm Sci 91:1414-1422
18. Amidon GL, Lennernas H, Shah VP et al (1995) Theoretical basis for a biopharmaceutical drug classifi cation: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413-420
19. Dressman JB, Amidon G, Reppas C, Shah VP (1998) Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res 15:11-22
20. Dressman J, Butler J, Hempenstall J et al (2001) The BCS: where do we go from here? Pharm Tech 25:68-76
21. Lachman L, Lieberman HA (2009) The theory and practice of industrial pharmacy, Special Indian edition. CBS, Chennai
22. http://www.accessdata.fda.gov, Dissolution methods. Accessed 5 May 2013
23. Brahmankar D, Jaiswal S (1995) Biopharmaceutics and Pharmacokinetics, a treaties, 1st edn. Vallabh Prakashan, New Delhi
24. Florence AT, Attwood D (1998) Physicochemical principles of pharmacy, 3rd edn. Creative Print & Design, Bristol
25. Martin AN, Bustamante P, Chun AH (1993) Physical pharmacy, 4th edn. Lea and Febiger, Philadilphia
26. Falbe J (1987) Surfactants in consumer products. Springer, Berlin
27. Kunieda H, Umizu G, Yamaguchi Y (1999) Mixing effect of polyethylene type nonionic surfactants on the liquid crystalline structures. J Colloid Interface Sci 218:88-96
28. Graham DE, Phillips MC (1976) In: Smith AL (ed) Theory and practice of emulsion technology. Academic, New York
29. Napper DH (1983) Polymeric stabilization of colloidal dispersion. Academic, New York
30. Clayfield EJ, Lumb EC (1968) Macromolecules 1:133
31. Friberg SE (ed) (1976) Food emulsion. Marcel Dekker, New York
32. Vold RD, Groot RC (1963) Parameters of emulsion stability. J Soc Cosmet Chem 14:233-244
33. Garrett ER (1970) Prediction and evaluation of emulsion stability with ultracentrifugal stress. J Soc Cosmet Chem 21:393-415
34. Rieger MM (1991) Stability testing of macroemulsions. Cosmet Toilet 106(5):59-69
35. Dollo G et al (2003) Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs. Eur J Pharm Sci 19:273-280
36. Levy MY, Benita S (1990) Drug release from submicronized o/w-emulsion: a new in vitro kinetic evaluation model. Int J Pharm 66:29-37
37. Takeuchi H, Sasaki H, Niwa T, Hino T et al (1992) Improvement of photostability of ubidecarenone in the formulation of a novel powdered dosage form termed redispersible dry emulsion. Int J Pharm 86:25-33
38. Lieberman HA, Rieger MM, Banker GS (1996) Pharmaceutical dosage form: Disperse systems, vol 1, 2nd edn. Informa healthcare, New York
39. Yong-Mei Y et al (2009) Preparation, characterization and in vitro intestinal absorption of a dry emulsion formulation containing atorvastatin calcium. Drug Deliv 16(1):30-36
40. Pedersen GP, Kristensen HG (1998) Solid state characterisation of a dry emulsion: a potential drug delivery system. Int J Pharm 171:257-270
41. Wagner JG, Gerard ES, Kaiser DG (1966) The effect of the dosage form on serum levels of indoxole. Clin Pharmacol Ther 7:610-619
42. Engel RH, Riggi SJ (1969) Intestinal absorption of heparin: a study of the interactions of components of oil-in-water emulsions. J Pharm Sci 58:1372-1375
43. Nishigaki R, Awazu S, Hanano M, Fuwa T (1976) The effect of dosage form on absorption of Vit A into lymph. Chem Pharm Bull 24:3207-3211
44. Sha X, Yan G, Wu Y, Li J, Fang V (2005) Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci 24:477-486
45. Dabholkar RD (2006) Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int J Pharm 315:148-157
46. Rege BD (2002) Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci 16:237-246